Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

• Κύριοι συγγραφείς: Alistair Ring (Συγγραφέας), Meghan Karuturi (Συγγραφέας), Emily Nash Smyth (Συγγραφέας), Tasneem Lokhandwala (Συγγραφέας), Kristin M. Sheffield (Συγγραφέας), Joanne Willey (Συγγραφέας), Orsolya Lunacsek (Συγγραφέας), Francisco Sapunar (Συγγραφέας), Zhanglin Lin Cui (Συγγραφέας), Anna D. Coutinho (Συγγραφέας), Sarah Rybowski (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Adis, Springer Healthcare, 2023-09-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Introduction Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) is the most frequently diagnosed metastatic breast cancer (mBC) subtype. Combinations of endocrine therapy (ET) with cyclin-dependent kinase 4/6 inhibitors (CDK4 & 6is) improve outcome...